A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance

Not Applicable

Completed

• Conditions: Sleep; Sleep Disorder

• Registration Number: NCT07183735
• Lead Sponsor: Beam

Brief Summary

This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-02
• Primary Completion: 2024-10-17
• Study Completion: 2024-10-17
• Study First Submitted: 2025-08-07
• Status Verified: 2025-09
• Study First Submitted QC: 2025-09-14
• Last Update Submitted: 2025-09-14
• Study First Posted: 2025-09-19
• Last Update Posted: 2025-09-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Male or female
• 18+ years old
• Self-reported issues with sleeping, falling asleep, or staying asleep.
• Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration.
• Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial.
• Willing to maintain their standard sleep pattern and activity level for the duration of the study.
• Be generally healthy and not live with any uncontrolled chronic disease.

Exclusion Criteria

• Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea.
• Women who are pregnant, breastfeeding, or trying to conceive.
• Anyone unwilling or unable to follow the study protocol.
• Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
• Is currently undergoing, or planning to undergo, any significant medical procedures during the study period.
• Has undergone any surgeries or invasive treatments in the last six months.
• A history of severe allergic reactions, including but not limited to any of the product's ingredients.
• Anyone with a nut allergy.
• Heavy drinkers. A heavy drinker is considered to be a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week.
• Anyone who uses illicit drugs.
• Use any prescription medication, over-the-counter, or herbal remedies that can affect sleep.
• Have a job that involves working the third or night shifts.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Change in sleep quality as measured by the Sleep Quality Scale (SQS)	Baseline, Week 2, Week 4, Week 6	Sleep quality will be assessed using the self-reported Sleep Quality Scale (SQS), a validated questionnaire evaluating subjective sleep quality.
Change in sleep quantity and architecture as measured by sleep tracker	Baseline, Week 2, Week 4, Week 6	Objective sleep metrics (e.g., time to fall asleep, deep sleep, REM sleep, sleep transitions, sleep duration, and frequency of waking) will be collected using a sleep tracking device.

Secondary Outcome Measures

Name	Time	Method
Change in perceived restfulness as measured by self-reported questionnaire	Baseline, Week 2, Week 4, Week 6	Participants will report perceived restfulness levels to assess subjective recovery and rest post-intervention.
Change in overall energy levels as measured by self-reported questionnaire	Baseline, Week 2, Week 4, Week 6	Participants will rate their energy levels using a structured questionnaire.
Change in emotional well-being as measured by self-reported questionnaire	Baseline, Week 2, Week 4, Week 6	Emotional well-being will be assessed using a validated self-report measure.
Change in cognitive function as measured by self-reported questionnaire	Baseline, Week 2, Week 4, Week 6	Cognitive function will be assessed through a participant questionnaire evaluating attention, memory, and mental clarity.
Change in dietary behavior (e.g., hunger levels) as measured by self-reported questionnaire	Baseline, Week 2, Week 4, Week 6	Participants will report perceived hunger levels and related dietary behavior using a structured questionnaire.

Trial Locations

Locations (1)

Citruslabs; 🇺🇸 Las Vegas, Nevada, United States